Ageing kills 83% of Americans. It gets 0.8% of the research budget.
Following the launch of A4LI’s new policy report, we look at how research funding relates to the impact of diseases.
Longevity News.
- All
- Business
- Demography
- GLP-1
- LI news
- Longevity medicine
- Media
- Pets
- Policy
- Research funding
- Science
- United States
Ageing kills 83% of Americans. It gets 0.8% of the research budget.
Following the launch of A4LI’s new policy report, we look at how research funding relates to the impact of diseases.
Can longevity save us from a population crisis?
Everyone’s worried about falling birth rates. Almost no one is talking about the other lever that could reshape our demographic future: longevity.
Why 2025 was longevity’s biggest year so far: Netflix, new laws and immortal dictators
From Bryan Johnson’s viral biohacking to Putin and Xi discussing living to 150, we examine 2025’s biggest longevity stories—and whether hype is helping or hurting science.
Longevity clinics, peptide risks and does Ozempic slow ageing? The last year in longevity medicine
Longevity clinics take off while biohackers at RAADFest are hospitalised after unregulated peptide injections: we review 2025 in longevity medicine.
Budget cuts, mega-prizes, and the future of longevity funding
40% cuts are proposed to US funding of longevity science, while the $101 million XPRIZE Healthspan—the world’s largest prize—announces 100 semi-finalists.
The business of longevity in 2025: big bets amid biotech bust
Billion-dollar bets on cellular reprogramming, biotech’s rough year, and early FDA success for healthy lifespan extension in dogs.
